Parexel International News and Activities

Parexel International is a company listed under the stock ticker PRXL (US).

Parexel International has a direct presence in 2 countries.

View the org chart displaying its 36 main executives

Most searched biographies at Parexel International

• Peyton Howell, Chief Executive Officer
• John Groetelaars, Director
• Jeff Bernstein, Director

Popular executive movements at Parexel International

• Rob Goodwin has joined the company as Chief Operating Officer  (posted on September 17 2025).

Create your alert
to follow the executive moves at Parexel International.

Parexel International has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Parexel International

Social media about Parexel International

• Parexel International on Wikipedia, Google News & Yahoo Finance
• Parexel International on LinkedIn, X (Twitter) & YouTube